Print Page  |  Close Window


ChardanGbola Amusa, MD, CFA
H.C. Wainwright Swayampakula Ramakanth, Ph.D. (RK)
JMP SecuritiesMichael King, Jr.
Piper JaffrayCharles C. Duncan, PhD.
Roth Capital PartnersSa`ar Yaniv
VBL Therapeutics is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding VBL Therapeutics's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of VBL Therapeutics or its management. VBL Therapeutics does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.